SSA
USNA icon

Schonfeld Strategic Advisors’s Usana Health Sciences USNA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,600
Closed -$370K – 3033
2022
Q3 		$370K Buy
+6,600
New +$436K ﹤0.01% 1953
2021
Q4 		– Sell
-2,200
Closed -$203K – 2562
2021
Q3 		$203K Sell
2,200
-500
-19% -$48.1K ﹤0.01% 1755
2021
Q2 		$277K Buy
+2,700
New +$271K ﹤0.01% 1515
2019
Q3 		– Sell
-2,700
Closed -$214K – 1253
2019
Q2 		$214K Sell
2,700
-2,700
-50% -$214K 0.01% 873
2019
Q1 		$453K Buy
5,400
+952
+21% +$99.4K 0.02% 721
2018
Q4 		$524K Buy
4,448
+1,248
+39% +$144K 0.02% 644
2018
Q3 		$386K Buy
+3,200
New +$397K 0.02% 629

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's USNA Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of Usana Health Sciences (USNA) in Q4 2022, closing a stake of 6,600 shares — an estimated $370K sold.

Schonfeld Strategic Advisors first reported a position in USNA in Q3 2018 and held it in 7 quarters. The position peaked at $524K in Q4 2018. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining Usana Health Sciences position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 6,600 Usana Health Sciences shares in Q4 2022, an estimated $370K.
  • Schonfeld Strategic Advisors first reported a position in Usana Health Sciences in Q3 2018 and held it in 7 quarters.
  • Schonfeld Strategic Advisors's Usana Health Sciences position peaked at $524K in Q4 2018.
  • 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.